Medicine Grand Rounds

Lionel D. Lewis, MA, MB.BChir, MD, FRCP

Professor of Medicine and of Pharmacology and Toxicology

The Geisel School of Medicine

Dartmouth College

8:00 a.m. – 9:00 a.m.

Auditorium E, Rubin Building, Dartmouth-Hitchcock Medical Center

Dr. Lewis received his BA and MA from Trinity College Cambridge, England in medical sciences and biochemistry. He received his clinical training in Medicine at the University of Wales College of Medicine, graduating Bachelor of Medicine /Bachelor of Surgery (MB.BCh) in 1977.  He completed his residency training at the University of Wales Hospital in Cardiff and became a Lecturer in Clinical Pharmacology at Guy’s Hospital, London from 1982-1989. He gained his Doctorate in Medicine (MD) from the University of Wales in 1988, and from 1989-91 he was a Fellow in Clinical Pharmacology at The Johns Hopkins Hospital. Dr. Lewis was appointed as Assistant Professor of Medicine, Pharmacology &Toxicology at Dartmouth Medical School in 1993 and was promoted to full Professor of Medicine, Pharmacology & Toxicology in 2003. He co-directs the Norris Cotton Cancer Center at Dartmouth Molecular Therapeutics Program and the NCC Phase-I group, is Director of the Clinical Pharmacology Shared Resource and Medical Director of the Dartmouth Clinical Trials Office. 

He was the first American Editor for the British Journal of Clinical Pharmacology (BJCP) from Jan 2005- Dec 2013, and is a BJCP International Editor and Reviews Board Member. He has also served on the Editorial Board of Clinical Pharmacology & Therapeutics, Cancer Chemotherapy Pharmacology and Human & Experimental Toxicology, and is the current Executive Director of the American Board of Clinical Pharmacology.  

Dr. Lewis is the vice chair of the Pharmacogenetics and Population Pharmacology committee of the Alliance of Clinical Trials in Oncology, an NCI intergroup. He has served on, and chaired, several DOD and NIH study section panels. He has more than 150 peer reviewed manuscripts on Clinical Pharmacology topics and has edited/co-authored several textbooks in the field. His research is funded by NCI, NCATs and several major Pharmaceutical Companies.

His main area of interest in clinical pharmacology is the clinical pharmacology (PK-PD) of anticancer drugs and their human metabolism. Dr. Lewis has extensive experience in first-in-man studies of new drugs and proof of principle studies with a particular focus on the Phase-I investigation of novel anti-cancer agents.

If you are unable to attend and would like to either view Grand Rounds live on your computer or if you would like to view it another time, please use this link.

http://med.dartmouth-hitchcock.org/education/dept_medicine_grand_rounds_live.html

The office of Continuing Medical Education will not be able to give you credit unless you use the mobile sign in. If you need to claim credit more than 48 hours after the conference you will need to contact clpd.support@hitchcock.org.

** The Dartmouth-Hitchcock Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education programs for physicians.**

** The Dartmouth-Hitchcock Medical Center designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. **